2012 Drug Pipeline : R&D turns to specialty therapies with less generic exposure Cardiometabolic Disease (Part 1) : The pharmacist’s tools for managing dyslipidemia and hypertension Rehabilitating the impaired pharmacist DeKalb and Walgreens discharge med service
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.